The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases

Research output: Contribution to journalReviewResearchpeer-review

Standard

The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases. / Luppi, Fabrizio; Manfredi, Andreina; Faverio, Paola; Andersen, Michael Brun; Bono, Francesca; Pagni, Fabio; Salvarani, Carlo; Bendstrup, Elisabeth; Sebastiani, Marco.

In: BMC Pulmonary Medicine, Vol. 23, No. 1, 501, 2023.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Luppi, F, Manfredi, A, Faverio, P, Andersen, MB, Bono, F, Pagni, F, Salvarani, C, Bendstrup, E & Sebastiani, M 2023, 'The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases', BMC Pulmonary Medicine, vol. 23, no. 1, 501. https://doi.org/10.1186/s12890-023-02783-z

APA

Luppi, F., Manfredi, A., Faverio, P., Andersen, M. B., Bono, F., Pagni, F., Salvarani, C., Bendstrup, E., & Sebastiani, M. (2023). The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases. BMC Pulmonary Medicine, 23(1), [501]. https://doi.org/10.1186/s12890-023-02783-z

Vancouver

Luppi F, Manfredi A, Faverio P, Andersen MB, Bono F, Pagni F et al. The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases. BMC Pulmonary Medicine. 2023;23(1). 501. https://doi.org/10.1186/s12890-023-02783-z

Author

Luppi, Fabrizio ; Manfredi, Andreina ; Faverio, Paola ; Andersen, Michael Brun ; Bono, Francesca ; Pagni, Fabio ; Salvarani, Carlo ; Bendstrup, Elisabeth ; Sebastiani, Marco. / The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases. In: BMC Pulmonary Medicine. 2023 ; Vol. 23, No. 1.

Bibtex

@article{7b991c2db6ae47d7b55f34365075da2e,
title = "The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases",
abstract = "Usual Interstitial Pneumonia (UIP) is characterized by progression of lung parenchyma that may be observed in various autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis and connective tissue diseases. From a diagnostic point of view, a UIP pattern related to ARDs may display imaging and pathological features able to distinguish it from that related to IPF, such as the “straight-edge” sign at HRCT and lymphoplasmacytic infiltrates at histologic specimens. Multidisciplinary approach (MDD), involving at least pulmonologist, rheumatologist and radiologist, is fundamental in the differential diagnosis process, but MDD is also required in the evaluation of severity, progression and response to treatment, that is based on the combination of changes in symptoms, pulmonary function trends, and, in selected patients, serial CT evaluation. Differently from IPF, in patients with ARDs both functional evaluation and patient-reported outcomes may be affected by systemic involvement and comorbidities, including musculoskeletal manifestations of disease. Finally, in regards to pharmacological treatment, immunosuppressants have been considered the cornerstone of therapy, despite the lack of solid evidence in most cases; recently, antifibrotic drugs were also proposed for the treatment of progressive fibrosing ILDs other than IPF. In ARD-ILD, the therapeutic choice should balance the need for the control of systemic and lung involvements with the risk of adverse events from multi-morbidities and -therapies. Purpose of this review is to summarize the definition, the radiological and morphological features of the UIP pattern in ARDs, together with risk factors, diagnostic criteria, prognostic evaluation, monitoring and management approaches of the UIP-ARDs.",
keywords = "Antifibrotic treatment, Autoimmune rheumatic disease, Diagnosis, Immunomodulatory drug, Interstitial lung disease, Rheumatoid arthritis, Usual interstitial pneumonia",
author = "Fabrizio Luppi and Andreina Manfredi and Paola Faverio and Andersen, {Michael Brun} and Francesca Bono and Fabio Pagni and Carlo Salvarani and Elisabeth Bendstrup and Marco Sebastiani",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
doi = "10.1186/s12890-023-02783-z",
language = "English",
volume = "23",
journal = "B M C Pulmonary Medicine",
issn = "1471-2466",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases

AU - Luppi, Fabrizio

AU - Manfredi, Andreina

AU - Faverio, Paola

AU - Andersen, Michael Brun

AU - Bono, Francesca

AU - Pagni, Fabio

AU - Salvarani, Carlo

AU - Bendstrup, Elisabeth

AU - Sebastiani, Marco

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2023

Y1 - 2023

N2 - Usual Interstitial Pneumonia (UIP) is characterized by progression of lung parenchyma that may be observed in various autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis and connective tissue diseases. From a diagnostic point of view, a UIP pattern related to ARDs may display imaging and pathological features able to distinguish it from that related to IPF, such as the “straight-edge” sign at HRCT and lymphoplasmacytic infiltrates at histologic specimens. Multidisciplinary approach (MDD), involving at least pulmonologist, rheumatologist and radiologist, is fundamental in the differential diagnosis process, but MDD is also required in the evaluation of severity, progression and response to treatment, that is based on the combination of changes in symptoms, pulmonary function trends, and, in selected patients, serial CT evaluation. Differently from IPF, in patients with ARDs both functional evaluation and patient-reported outcomes may be affected by systemic involvement and comorbidities, including musculoskeletal manifestations of disease. Finally, in regards to pharmacological treatment, immunosuppressants have been considered the cornerstone of therapy, despite the lack of solid evidence in most cases; recently, antifibrotic drugs were also proposed for the treatment of progressive fibrosing ILDs other than IPF. In ARD-ILD, the therapeutic choice should balance the need for the control of systemic and lung involvements with the risk of adverse events from multi-morbidities and -therapies. Purpose of this review is to summarize the definition, the radiological and morphological features of the UIP pattern in ARDs, together with risk factors, diagnostic criteria, prognostic evaluation, monitoring and management approaches of the UIP-ARDs.

AB - Usual Interstitial Pneumonia (UIP) is characterized by progression of lung parenchyma that may be observed in various autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis and connective tissue diseases. From a diagnostic point of view, a UIP pattern related to ARDs may display imaging and pathological features able to distinguish it from that related to IPF, such as the “straight-edge” sign at HRCT and lymphoplasmacytic infiltrates at histologic specimens. Multidisciplinary approach (MDD), involving at least pulmonologist, rheumatologist and radiologist, is fundamental in the differential diagnosis process, but MDD is also required in the evaluation of severity, progression and response to treatment, that is based on the combination of changes in symptoms, pulmonary function trends, and, in selected patients, serial CT evaluation. Differently from IPF, in patients with ARDs both functional evaluation and patient-reported outcomes may be affected by systemic involvement and comorbidities, including musculoskeletal manifestations of disease. Finally, in regards to pharmacological treatment, immunosuppressants have been considered the cornerstone of therapy, despite the lack of solid evidence in most cases; recently, antifibrotic drugs were also proposed for the treatment of progressive fibrosing ILDs other than IPF. In ARD-ILD, the therapeutic choice should balance the need for the control of systemic and lung involvements with the risk of adverse events from multi-morbidities and -therapies. Purpose of this review is to summarize the definition, the radiological and morphological features of the UIP pattern in ARDs, together with risk factors, diagnostic criteria, prognostic evaluation, monitoring and management approaches of the UIP-ARDs.

KW - Antifibrotic treatment

KW - Autoimmune rheumatic disease

KW - Diagnosis

KW - Immunomodulatory drug

KW - Interstitial lung disease

KW - Rheumatoid arthritis

KW - Usual interstitial pneumonia

U2 - 10.1186/s12890-023-02783-z

DO - 10.1186/s12890-023-02783-z

M3 - Review

C2 - 38082233

AN - SCOPUS:85179372619

VL - 23

JO - B M C Pulmonary Medicine

JF - B M C Pulmonary Medicine

SN - 1471-2466

IS - 1

M1 - 501

ER -

ID: 377811398